Test Questions

Treatment Options in Acute Lung Injury and Acute Respiratory Distress Syndrome

Exam Questions

1. Acute respiratory distress syndrome (ARDS) is best described as:
    A. An acute pulmonary inflammatory condition
    B. A chronic pulmonary inflammatory condition
    C. An acute episode of pulmonary congestion
    D. An acute pulmonary obstruction
2. Risk factors for the development of acute lung injury (ALI)/ARDS include all of the following except:
    A. Chronic obstructive pulmonary disease
    B. Multiple transfusions
    C. Sepsis
    D. Pneumonia
3. All of the following are diagnostic criteria for ARDS except:
    A. Pulmonary capillary wedge pressure (PCWP) of less than 18 mmHg
    B. Partial pressure of arterial oxygen to fraction of inspired oxygen (PF) ratio of less than 200
    C. Bilateral infiltrates on chest radiograph
    D. PF ratio of less than 300
4. Which of the following laboratory tests may be useful in differentiating cardiogenic from noncardiogenic edema?
    A. C-reactive protein
    B. PCWP
    C. Brain natriuretic protein
    D. Both A and B
5. The exudative phase of ALI/ARDS is characterized by:
    A. Protein-rich pulmonary edema
    B. Pulmonary fibrosis
    C. Loss of coagulation homeostasis
    D. Both A and C
6. Which phase of ALI/ARDS is characterized by alveolar and intimal fibrosis?
    A. Exudative
    B. Proliferative
    C. Fibrotic
    D. Recovery
7. The ideal tidal volume for lung-protective mechanical ventilation is:
    A. 6 mL/kg of actual body weight
    B. 6 mL/kg of ideal body weight
    C. 12 mL/kg of actual body weight
    D. 12 mL/kg of ideal body weight
8. Which of the following therapies has proven efficacy in the treatment of ARDS?
    A. Prone positioning of patient
    B. Low-tidal-volume ventilation
    C. Corticosteroids
    D. Beta-adrenergic agonists
9. Fluid-management strategies that improve oxygenation include:
    A. Conservative fluid management
    B. Liberal fluid management
    C. Albumin plus furosemide
    D. Both A and C
10. Which of the following is true of permissive hypercapnia?
    A. Should be avoided in ARDS/ALI patients
    B. Results when excessive oxygen is retained
    C. Results when lung-protective mechanical ventilation is used
    D. All of the above
11. Corticosteroids have been shown to accomplish all of the following in ALI/ARDS except:
    A. Reduce overall hospital mortality
    B. Shorten ICU stay
    C. Reduce number of ventilator days
    D. Reduce number of shock-free days
12. Which of the following statements is (are) true regarding activated protein C (APC) in ALI/ARDS?
    A. Current guidelines for managing sepsis support the use of APC in patients with severe sepsis and ARDS
    B. Patients with ARDS have low levels of APC
    C. Both A and B
    D. Neither A nor B
13. The proposed beneficial effect of beta-adrenergic agonists in the treatment of ALI/ARDS is:
    A. Anti-inflammatory action
    B. Clearance of alveolar fluid
    C. Pulmonary vasodilation
    D. All of the above
14. The following medication is effective for ALI/ARDS because of its anti-inflammatory properties:
    A. Albuterol
    B. Methylprednisolone
    C. Nitric oxide
    D. Pentoxifylline
15. An adverse effect of beta-adrenergic agonists is:
    A. Tachycardia
    B. Supraventricular arrhythmias
    C. Atrial fibrillation
    D. Both A and B
16. The following match is correct for ALI/ARDS pharmacotherapy:
    A. N-acetylcysteine; antioxidant
    B. Corticosteroids; antioxidant
    C. Ketoconazole; antioxidant
    D. Both A and C
17. Resolution of ALI/ARDS is associated with all of the following symptoms except:
    A. Removal of protein-rich edema from the lungs
    B. Clearance of inflammatory cells
    C. Restoration of normal alveolar function
    D. Normal tissue perfusion
18. Nitric oxide is best described as a(n):
    A. Vasoconstrictor
    B. Nonselective vasodilator
    C. Selective vasodilator
    D. Anti-inflammatory agent
19. Ketoconazole is best described as a(n):
    A. Anti-inflammatory agent
    B. Nonselective vasodilator
    C. Antioxidant
    D. Anticoagulant
20. Tissue factor pathway inhibitor is thought to be effective in the treatment of ALI/ARDS because of its __________ effect:
    A. Anti-inflammatory
    B. Anticoagulant
    C. Antioxidant
    D. Vasodilatory

Evaluation Questions

21. Met objective 1:*
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
22. Met objective 2:*
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
23. Met objective 3:*
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
24. Met objective 4:
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
    F. N/A for Pharmacy Technicians
25. Related to your educational needs:
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
26. The active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
27. Avoided commercial bias:
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
28. How would you rate the overall usefulness of the material presented?
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
29. How would you rate the quality of the faculty?
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
30. How would you rate the appropriateness of the examination for this activity?
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
31. Comments on this program:
 
* Also applies to pharmacy technicians